Corebridge Financial (CRBG) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Achieved or exceeded 2024 financial goals: 12.8% adjusted ROAE, 81% payout ratio, and RBC ratio over 420%.
Operating earnings per share rose 18% to $4.83; $2.3 billion returned to stockholders via dividends and buybacks.
Board transitioned to majority-independent, with new committees and independent Chair; AIG reduced ownership, Nippon and Blackstone added directors.
Strategic initiatives include digital transformation, data analytics, and workplace improvements.
Forward-looking statements highlight ongoing focus on growth, efficiency, and risk management.
Voting matters and shareholder proposals
Election of thirteen director nominees for one-year terms.
Advisory vote to approve 2024 executive compensation.
Ratification of PricewaterhouseCoopers LLP as independent auditor for 2025.
Proxy access allows eligible stockholders to nominate directors in future proxy materials.
Board of directors and corporate governance
Board now 62% independent, with new independent Chair and four new independent directors added since 2024.
Three new committees established: Nominating and Corporate Governance, Compensation and Management Development, and Risk.
Board diversity: 30.8% female, average age 59.8 years, broad mix of skills and backgrounds.
Annual board and committee self-assessments; robust stock ownership and clawback policies.
Directors generally retire at 75; majority voting in uncontested elections.
Latest events from Corebridge Financial
- Record sales, robust capital return, and reduced risk support a strong 2026 outlook.CRBG
Q4 202510 Feb 2026 - Premiums up 17%, operating EPS up 9%, and strong capital returns in Q2 2024.CRBG
Q2 20242 Feb 2026 - Strong growth, disciplined capital management, and product innovation drive long-term value.CRBG
Barclays 23rd Annual Global Financial Services Conference21 Jan 2026 - Adjusted operating income up 27% year-over-year despite a $1.2B net loss.CRBG
Q3 202416 Jan 2026 - 2024 EPS up 18%, $2.3B returned to shareholders, and strong segment growth achieved.CRBG
Q4 20248 Jan 2026 - Delivering on growth, efficiency, and capital return targets while expanding product and distribution.CRBG
KBW Insurance Conference 20255 Jan 2026 - Stockholders will vote on charter amendments for Board by-law authority and written consent rights.CRBG
Proxy Filing2 Dec 2025 - Stockholders will vote on Board by-law authority and a 25% threshold for written consent action.CRBG
Proxy Filing2 Dec 2025 - Key votes include director elections, executive pay, and auditor ratification for 2025.CRBG
Proxy Filing2 Dec 2025